UPDATE 2-AstraZeneca pulls submissions for lung cancer drug
October 28th, 2009
AstraZeneca (AZN.L) has pulled regulatory submissions for its experimental drug Zactima plus chemotherapy as a treatment for lung cancer, dealing a blow to its new product pipeline and hitting its shares.